Quality management of a large randomized double-blind multi-centre trial: The ACTION experience
- 31 March 2008
- journal article
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 29 (2) , 259-269
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialThe Lancet, 2005
- Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trialThe Lancet, 2004
- Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololThe Lancet, 2002
- The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized TrialsJAMA, 2001
- Societal responsibilities of clinical trial sponsorsBMJ, 2001
- Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibilityCommentary: Early discontinuation violates Helsinki principlesBMJ, 2001
- Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) studyThe Lancet, 2000
- What is meant by intention to treat analysis? Survey of published randomised controlled trialsBMJ, 1999
- Guidelines for Quality Assurance in Multicenter Trials: A Position PaperControlled Clinical Trials, 1998
- Prospective Randomized Open Blinded End-point (PROBE) Study. A novel design for intervention trialsBlood Pressure, 1992